A case of hyperprogressive disease following atezolizumab therapy for pulmonary pleomorphic carcinoma with epidermal growth factor receptor mutation.
Epidermal growth factor receptor (EGFR) mutation
Hyperprogressive disease (HPD)
Immune-checkpoint inhibitor (ICI)
Immune-related adverse events (irAE)
Pulmonary pleomorphic carcinoma
Journal
Respiratory medicine case reports
ISSN: 2213-0071
Titre abrégé: Respir Med Case Rep
Pays: England
ID NLM: 101604463
Informations de publication
Date de publication:
2021
2021
Historique:
received:
20
11
2020
revised:
03
03
2021
accepted:
22
03
2021
entrez:
19
4
2021
pubmed:
20
4
2021
medline:
20
4
2021
Statut:
epublish
Résumé
A 66-year old man with non-smoking history was diagnosed with pulmonary pleomorphic carcinoma of the right lower lobe. The carcinoma metastasized to the brain, lungs, pleura, and mediastinal lymph nodes. It was positive for
Identifiants
pubmed: 33868915
doi: 10.1016/j.rmcr.2021.101405
pii: S2213-0071(21)00067-8
pmc: PMC8042444
doi:
Types de publication
Journal Article
Langues
eng
Pagination
101405Informations de copyright
© 2021 The Author(s).
Déclaration de conflit d'intérêts
The authors declare that there is no conflict of interests regarding the publication of this article.
Références
Clin Cancer Res. 2019 Feb 1;25(3):989-999
pubmed: 30206165
J Thorac Oncol. 2010 Apr;5(4):460-5
pubmed: 20107421
J Clin Oncol. 2018 Jun 10;36(17):1714-1768
pubmed: 29442540
Ther Adv Med Oncol. 2020 Jul 20;12:1758835920915983
pubmed: 32733604
Thorac Cancer. 2020 Oct;11(10):2793-2803
pubmed: 32779394
N Engl J Med. 2020 Oct 1;383(14):1328-1339
pubmed: 32997907
Lancet. 2017 Jan 21;389(10066):255-265
pubmed: 27979383
Mol Cancer. 2020 May 2;19(1):81
pubmed: 32359357
Ann Oncol. 2019 Mar 1;30(3):385-396
pubmed: 30657859
Clin Cancer Res. 2017 Apr 15;23(8):1920-1928
pubmed: 27827313
Cancer. 2019 Apr 15;125(8):1341-1349
pubmed: 30768786
Nat Rev Cancer. 2013 Feb;13(2):83-96
pubmed: 23303139
Proc Natl Acad Sci U S A. 2019 May 14;116(20):9999-10008
pubmed: 31028147
JAMA Oncol. 2018 Nov 1;4(11):1543-1552
pubmed: 30193240
Clin Cancer Res. 2017 Aug 1;23(15):4242-4250
pubmed: 28351930
Ann Oncol. 2017 Jul 1;28(7):1605-1611
pubmed: 28419181
Cell. 2015 Sep 10;162(6):1242-56
pubmed: 26359984
J Thorac Oncol. 2017 Feb;12(2):403-407
pubmed: 27765535
Anticancer Drugs. 2019 Nov;30(10):1067-1070
pubmed: 31567311
Lung Cancer. 2001 Oct;34(1):91-7
pubmed: 11557118